Radcliffe Nathan M

Ferguson Tanner J, Samuelson Thomas W, Herndon Leon, Terveen Daniel C, Bacharach Jason, Brubaker Jacob W et al.

This study found an ocular pressure adjusting pump safely and effectively lowered both day and night intraocular pressure in normal-tension glaucoma patients, offering a new treatment option.

Radcliffe Nathan M, Harris Jennifer, Garcia Kristian, Zwick Erin, Chang Robert T, Mbagwu Michael

Standalone OMNI surgery for POAG significantly reduced IOP and/or medication use for up to 36 months, making it a viable MIGS option for sustained pressure and medication reduction.

Kahook Malik Y, Rapuano Christopher J, Messmer Elisabeth M, Radcliffe Nathan M, Galor Anat, Baudouin Christophe

Preservatives in glaucoma drops, especially BAK, cause ocular surface disease. Reducing/eliminating BAK via preservative-free options or non-pharmacological treatments improves patient quality of life and surgical outcomes.

Roth Daniel B, Eichenbaum David, Malik Deepika, Radcliffe Nathan M, Cutino Antonio, Small Kent W

This study found the 0.19-mg FAc implant for DME resulted in relatively stable IOP over 36 months, with elevations not significantly impacting long-term vision. Routine IOP monitoring remains crucial.

Tan Nicholas E, Chen Shannon X, Radcliffe Nathan M

This study found that in Black/Hispanic patients undergoing glaucoma valve surgery, hypertensive phase and baseline visual field damage increased 1-year vision loss risk, while concurrent cataract surgery decreased it.

Realini Tony, Gupta Preeya K, Radcliffe Nathan M, Garg Sumit, Wiley William F, Yeu Elizabeth et al.

Glaucoma and its treatments can cause corneal endothelial cell loss. Clinicians should consider corneal health when choosing glaucoma therapies, especially with pre-existing low cell density.

Swan Russell J, Ferguson Tanner J, Shah Manjool, Muir Kelly W, Samuelson Thomas W, Ahmed Iqbal Ike K et al.

A multi-pressure dial applying negative pressure around the eye safely and effectively lowered intraocular pressure in a titratable manner, offering a novel non-pharmacologic glaucoma treatment strategy.

Tracer Nathaniel, Ayoub Samantha, Radcliffe Nathan M

This study found that lower corneal hysteresis (CH) was associated with greater IOP reduction after microinvasive glaucoma surgery (MIGS), but also an increased need for further intervention.

Radcliffe Nathan M

Greenwood Michael D, Seibold Leonard K, Radcliffe Nathan M, Dorairaj Syril K, Aref Ahmad A, Román Jesús Jimenez et al.

Single-use dual blade goniotomy with cataract surgery significantly lowered IOP and medication use in glaucoma patients for 6 months, offering an effective treatment option.

Rathi Siddarth, Radcliffe Nathan M

This review found combined cataract surgery and ECP effectively lowers eye pressure and medication needs in moderate glaucoma with minimal side effects, preserving future treatment options.

Deol Madhvi, Ehrlich Joshua R, Shimmyo Mitsugu, Radcliffe Nathan M

This study found lower baseline corneal hysteresis predicts a greater long-term IOP reduction after cataract surgery, suggesting it may help identify patients who will experience a more significant pressure drop.

Hussnain Syed Amal, Alsberge Joseph B, Ehrlich Joshua R, Shimmyo Mitsugu, Radcliffe Nathan M

This study found corneal hysteresis declines faster in glaucoma patients than in normal eyes, suggesting it could be a useful marker for glaucoma progression.

Deol Madhvi, Taylor David A, Radcliffe Nathan M

Low corneal hysteresis is linked to glaucoma damage and progression, potentially improving IOP interpretation and predicting treatment response, making it a valuable clinical tool.

Van Tassel Sarah H, Radcliffe Nathan M, Demetriades Anna M

This review summarized 2013-2014 glaucoma research, highlighting new pathophysiology, diagnostic, and treatment approaches valuable for clinicians and future developments.

Chung Esther, Demetriades Anna M, Christos Paul J, Radcliffe Nathan M

This study found glaucoma structural progression occurs both before and after optic disc hemorrhage, suggesting DH is part of ongoing progression, not a trigger for new decline.

Radcliffe Nathan M, Smith Scott D, Syed Zeba A, Park Sung Chul, Ehrlich Joshua R, De Moraes Carlos Gustavo et al.

Studying glaucoma patients, retinal blood vessel shifts were linked to faster visual field loss and structural damage, suggesting a novel marker for identifying disease progression.

McGlynn Margaret M, Ehrlich Joshua R, Marlow Elizabeth D, Chee Ru-Ik, Silva Fabiana Q, Van Tassel Sarah H et al.

This study found lower diastolic blood pressure is linked to structural glaucoma progression (RNFL/rim loss). This suggests managing blood pressure may be important for glaucoma care.

Vu Daniel M, Silva Fabiana Q, Haseltine Sarah J, Ehrlich Joshua R, Radcliffe Nathan M

This study found corneal hysteresis correlated better with visual field damage (MD) than with SD-OCT structural optic nerve parameters in glaucoma patients, suggesting its primary relevance for functional assessment.

Chee Ru-Ik, Silva Fabiana Q, Ehrlich Joshua R, Radcliffe Nathan M

Flicker chronoscopy showed acceptable agreement for detecting glaucoma progression. Age and lower corneal hysteresis were associated with progression, highlighting their clinical importance in monitoring.

Haseltine Sarah J, Pae Jennis, Ehrlich Joshua R, Shammas Maya, Radcliffe Nathan M

This study found Black subjects have lower corneal hysteresis (CH) and central corneal thickness (CCT). Crucially, CH differences persist independently of CCT, suggesting CH is a better measure for racial differences in corneal properties relevant to glaucoma.

Syed Zeba A, Radcliffe Nathan M, De Moraes Carlos Gustavo, Smith Scott D, Liebmann Jeffrey M, Ritch Robert

Automated flicker viewing significantly improved detection of optic disc hemorrhages in glaucoma patients compared to standard methods, offering a more sensitive tool for identifying active neurodegeneration.

Agarwal Daniel R, Ehrlich Joshua R, Shimmyo Mitsugu, Radcliffe Nathan M

This study found lower baseline corneal hysteresis predicts a greater IOP reduction with prostaglandin eye drops, suggesting it could help personalize glaucoma treatment.

Radcliffe Nathan M, Musch David C, Niziol Leslie M, Liebmann Jeffrey M, Ritch Robert

Unilateral trabeculectomy had no substantial effect on the untreated fellow eye's IOP, with only a small, transient decrease observed. This suggests trabeculectomy doesn't significantly lower fellow eye pressure.

VanderBeek Brian L, Smith Scott D, Radcliffe Nathan M

This study found that automated flicker technology detects more parapapillary atrophy progression and offers better inter-observer agreement than standard digital photography, improving glaucoma monitoring.